Intellectual Property Magazine
Illumina defeats Chinese rivals in UK patent ruling
Justice Colin Birss finds four asserted proprietary sequencing-by-synthesis chemistry patents to be valid and infringed by BGI Group
Ben Wodecki
US biotech firm Illumina received a favourable ruling from the High Court of England & Wales this week, in its ongoing patent
infringement dispute against several Chinese rivals.